Shortcuts
...
10:30-11:15
Moderator:
Esat GÖKTEPE
Clozapine: 55 years after as post discovery and its illumination of refractory schizophrenia
Y. MELTZER
11:30-12:15
Moderator:
Ümit YAŞAR
Novel pharmacotherapies in treatment of depression: Oxytocin for treatment of depression
Ziad NAHAS
13:00-14:30
Symposium-1: Pharmacogenetics, pharmacoresistance and therapeutic goals
Educational Updates Track
Moderators:
Alaattin DURAN
, Hasan HERKEN
Epigenetic mechanisms of psychiatric disorders and targets in treatment
Cengiz BAŞOĞLU
Effects of genetic differences on psychiatric disorders and treatment: "Individualized pharmacotherapy:" Myth or truth?
Nevzat TARHAN
What is the role of drug metabolisms in treatment resistance?
Ümit YAŞAR
Use of pharmacoEEG and EEG on drug selection and efficiency assessment : Myth or truth?
Kemal ARIKAN
Pharmacoresistance in psychiatry
Feyza ARICIOĞLU
14:45-16:15
Symposium-4 : From past to future: Resistance in schizophrenia, where are we and what can be done?
Symposia - Educational Updates Track
Moderators:
Erdal IŞIK
, Ertan TEZCAN
Description and neurobiology of treatment resistance in schizophrenia
Kâzım YAZICI
Relationship of early treatment and resistance: Can development of treatment-resistance be prevented in schizophrenia?
Baybars VEZNEDAROĞLU
Pharmacotherapeutic approaches in approaches in treatment-resistant schizophrenics
Ender TANER
Psychosocial approaches in treatment-resistant schizophrenics
Mustafa YILDIZ
16:30-17:15
Moderator:
M.Kerem DOKSAT
Optimizing clozapine treatment
David OSSER
17:30-18:15
Moderator:
Feyza ARICIOĞLU
Does the glutamatergic system play a role in the pathophysiology of mood disorders? Results from a clinical approach testing this hypothesis
Jorge QUIROZ
18:30-20:30
Educational Interactive Course
Fundamental biostatistics course
Cengiz AÇIKEL, Selim KILIÇ, Numan KONUK
13:00-14:30
Symposium-2 : Rational approach and treatment strategies in treatment resistant anxiety disorders
Symposia - Educational Updates Track
Moderators:
Bekir Aydın LEVENT
, Ali ÇAYKÖYLÜ
Rational approach and treatment strategies in treatment resistant generalized anxiety disorder
Nesrin DİLBAZ
Rational approach and treatment strategies in treatment resistant OCD
Hüsnü ERKMEN
Rational approach and treatment strategies in treatment resistant panic disorders
Neşe KOCABAŞOĞLU
Rational approach and treatment strategies in treatment of resistant social anxiety disorders
Hatice GÜZ
14:45-16:15
Symposium-5 : Serotonin dopamine antagonist antipsychotics in the treatment resistance from childhood to elderly: Their advantages and disadvantages
Symposia - Educational Updates Track
Moderators:
Aytekin SIR
, Sefa SAYGILI
Serotonin dopamine antagonist antipsychotics in childhood and adolescent: Can we prevent resistance at the beginning?
Salih ZOROĞLU
Parenteral serotonin dopamine antagonist antipsychotics in treatment of agitation: What do we have in hand?
Ömer BÖKE
Serotonin dopamin antagonists in patients with demetia: Their advantages and disadvantages
Engin EKER
Serotonin dopamin anatagonists in general psychiatry: Their advantages and disadvantages
M. Kerem DOKSAT
18:30-20:30
Educational Interactive Course
Cognitive functions in schizophrenia and recovery with drugs
Herbert Y. MELTZER
13:00-14:30
Symposium-3 : Psychotraumatology, psychotherapy, pharmacotherapy: Questions, problems, mastery and expertise
Symposia - Educational Updates Track
Moderators:
Yusuf ALPER
, Hakan TÜRKÇAPAR
Unseen part of the iceberg: The role of childhood traumas in resistant psychiatric disorders
Ümit Başar SEMİZ
The role and highlights of pharmacotherapeutic applications in resistant childhood traumas (DID, etc)
Vedat ŞAR
The role of pharmacotherapy in post-traumatic stress disorder: When, with and which drugs and how?
Oğuz KARAMUSTAFALIOĞLU
Does pharmacotherapy support or hinder psychotherapy? Questions, problems, mastery and expertise
Axel WUERZ
14:45-16:15
Neurobiology of Anxiety, Panic, and Fear: Where are we going?
Symposia - Dual Conference
Moderators:
Mustafa BİLİCİ
, Özcan UZUN
Periaqueductal gray matter, fear-like behaviour and drug effects
Lee Wei LIM
Neural pathways involved in fear, panic and anxiety
Nazan AYDIN
18:30-20:30
Educational Interactive Course
Psychopharmacological treatment of children and adolescents
Melissa DELBELLO
07:45-08:45
Educational Interactive Course
Brain stimulation treatments for treatment-resistant depression
Ziad NAHAS
09:00-10:30
Symposium-6 : Treatment resistance in bipolar disorders in all dimensions
Symposia Educational Updates Track
Moderators:
Sunar BİRSÖZ
, Medaim YANIK
The concept of treatment response from prodromal phase to resistance and the predictors in bipolar disorders
Kaan KORA
The reflections of treatment on brain imaging in mood disorders
Ayşegül ÖZERDEM
Subsyndromal signs and their effects on the therapeutic response in bipolar disorders
Timuçin ORAL
To overcome treatment resistance in bipolar disorders: What can be done?
Olcay YAZICI
11:00-11:45
Moderator:
İlhan YARĞIÇ
New developments in the treatment of alcoholism
Donald Hugh MYRICK
13:15-14:45
Symposium-9 : Changes in the tendency of prescribing psychopharmacological drugs
Educational Updates Track
Moderators:
Rüstem AŞKIN
, Fatih KARAASLAN
Changes between 2005-2007; general data Social Insurance Institute of Turkey
Hasan KARADAĞ
Factors determining prescribing tendencies
Sibel ORSEL
Pharmacoeconomic analysis of prescribing tendencies
Zafer GÜNEY
Drug industry-physician relations: Non-ethical factors that can influence drug prescribing tendencies
Hanefi ÖZBEK
What can be done against unethical prescribing tendencies of psychotrophic drugs?
İbrahim BALCIOĞLU
15:00-15:45
Moderator:
Haluk SAVAŞ
The pharmacologic management of treatment-resistant depression: Realities and fiction?
Andrew NIERENBERG
17:30-18:15
Moderator:
Yankı YAZGAN
Treatment-resistant cases in child and adolescent psychopharmalogy: Treatment and management
Melissa DELBELLO
18:30-21:00
Management of acute agitation in emergency settings
Jimmi NIELSEN
09:00-10:30
Symposium-7 : The variations of the response, adverse effects and neuroendocrine profile among antidepressants according to their action mechanisms
Treatment Track
Moderators:
İsmail AK
, İsmet KIRPINAR
Similarities and differences in mechanisms of antidepressant actions
Selçuk KIRLI
Similarities and differences in examples of treatment response
Cengiz AKKAYA
Adverse effects and tolerability profile: Similarities and differences
Yusuf SİVRİOĞLU
Similarities and differences from the perspective of impact on neuroendocrine profile
Saygın EKER
13:15-14:45
Symposium-10 : Addiction:Pharmacotherapy and other approaches in comorbid conditions
Educational Updates Track
Moderators:
Musa TOSUN
, Zehra ARIKAN
Pharmacotherapy alternatives in comorbid psychosis
Abdurrahman ALTINDAĞ
Pharmacotherapy alternatives in comorbid mood disorders
Ali DORUK
Pharmacotherapy alternatives in comorbid anxiety disorders
Cüneyt EVREN
Comprehensive therapeutic approaches in stress sensitivity and comorbid conditions in addiction
Berna ULUĞ
Childhood traumas in alcoholism
Hasan MIRSAL
18:30-21:00
Educational Interactive Course
Preparation of scientific papers in psychiatry
Murad ATMACA, Hasan HERKEN
09:00-10:30
Symposium-8 : Are many of psychiatric disorders are actually impulse control disorders?
Educational Updates Track
Moderators:
Fuat ÖZGEN
, Nihat ALPAY
Relationship between impulsivity and personality disorders
Servet EBRİNÇ
Relationship between impulsivity and obsessive compulsive disorder
Berna Binnur KIVIRCIK AKDEDE
Relationship between impulsivity and eating disorders
Fulya MANER
Relationship between impulsivity and suicidal behavior
Levent SEVİNÇOK
Relationship between impulsivity and addiction
Ertuğrul EŞEL
13:15-14:45
Symposium-11 : From childhood to elderly: Comorbid conditions and treatment masteries in treatment resistance
Educational Updates Track
Moderators:
Meral BERKEM
, Işın BARAL KULAKSIZOĞLU
Treatment strategies in ADHD and behavioral disorders
Osman SABUNCUOĞLU
ADHD's longterm impact in adulthood: Comorbidities, functionality and therapeutic dilemmas
Yankı YAZGAN
Treatment strategies in schizobsessive conditions
M. Murat DEMET
Pharmacological treatment strategies in elderly with comorbid medical conditions
Ayhan ALGÜL
18:30-21:00
Educational Interactive Course
Neuro-biological signs of therapy on the brain: Pharmacotherapy and cognitive therapy
Hakan TÜRKÇAPAR, Ali Saffet GÖNÜL
09:00-10:45
Symposium-12 : Pharmacological treatment approaches and recent advances in sexual function disorders
Symposia - Educational Updates Track
Moderators:
Hamdullah AYDIN
, Hayrettin KARA
The use of PDE5 inhibitors in treatment of erectile dysfunction is over 10 years. Where did we come in 10 years? Most recent pharmacological approaches
Lut TAMAM
Testestrone replacement therapies and what is the role of DHEA on the treatment of sexual frigidity in male and females?
Tayfun TURAN
What is “elderly hypogonadism” in man? What is the relationship of this with depression and sexual problems in man over 40
Selami ALBAYRAK
What are the positive and negative roles of antidepressants in sexual life
Selim GEÇİCİ
11:00-11:45
Moderator:
Ali Saffet GÖNÜL
Treatment resistant depression: The role of bipolar misdiagnosis
Nassir GHAEMI
13:15-14:45
Symposium-15 : How effective and ethical are the use of off-label treatments in resistant psychiatric disorders?
Symposia - Educational Updates Track
Moderators:
Orhan DOĞAN
, Aytekin ÖZŞAHİN
The high dose and combine antipsychotic applications in refractory schizophrenia
Alp ÜÇOK
The off- label drug use in addiction treatment (antidepressants, anticonvulsants etc.)
Hakan ÇOŞKUNOL
The off- label drug use in resistant bipolar disorders (protective antipsychotic, multiple anticonvulsants and augmentations)
Ömer AYDEMİR
The off-label drug use in resistant anxiety disorders (antipsychotics, anticonvulsants, long-term benzodiazepines and augmentations)
Tunç ALKIN
16:15-17:00
Moderator:
Ayşegül YILDIZ
Effectiveness of adjunctive antidepressant treatment for bipolar depression
Gary SACHS
17:00-17:45
Moderator:
Oğuz KARAMUSTAFALIOĞLU
IPL-10 : Use and misuse of antipsychotics (typical and atypical) in resistant anxiety
Joseph ZOHAR
09:00-10:45
Symposium-13 : From childhood and adolescence to adulthood: Treatment resistance and new solutions
Symposia - Treatment Track
Moderators:
Kemal AYDINALP
, Mücahit ÖZTÜRK
Psychopharmacolgical approaches in autism spectrum disorders: Treatment resistance symptom
Nahit Motavallı MUKADDES
Resistance and solutions in depression and bipolar disorder
Tümer TÜRKBAY
Resistance and solutions in anxiety disorders
Yasemen IŞIK TANER
Resistance and solutions in ADHD
Özgür ÖNER
Resistance and solutions in adult ADHD
Bengi SEMERCİ
13:15-14:45
Symposium-16 : Non-antidepressant treatment strategies in treatment resistant anxiety disorders: From older to new choices
Symposia - Treatment Track
Moderators:
Müfit UĞUR
, Salih BATTAL
The role of benzodiazepines in treatment resistant anxiety disorders
Nurper ERBERK ÖZEN
The role of atypical antipsychotics in resistant anxiety disorders
Şebnem PIRILDAR
The role of anticonvulsants in resistant anxiety disorders
Raşit TÜKEL
The role of complimentary medicine to avoid the adverse effects of long term drug use in resistant anxiety disorders
Armağan SAMANCI
18:00-19:00
Educational Interactive Course
Management of treatment resistant schizophrenia
Herbert Y. MELTZER
09:00-10:45
Symposium-14 : What do studies on the effectiveness and efficacy of psychotropic agents supported by the state and industry (i.e. CATIE, CAFE,EUFEST, CutLaSS, BOLDER I and II,STEP-BD, STAR-D) carried out after 2000 suggest? How should we understand and interpret the data from these studies ?
Symposia - Educational Updates Track
Moderators:
M. Yücel AĞARGÜN
, Mesut ÇETİN
The correct reading and interpretation of scientific papers: The principles and suggestions
Selim KILIÇ
From research to clinical experiences:Are antidepressants inefficent in the bipolar depression? Don't they cause manic shift as expected? The correct interpretation of STEP-BD
Haluk SAVAŞ
Atypical antipsychotics for the treatment of bipolar mania. How can we understand and interpret the results of scientific researches ( BOLDER-I and BOLDER-II, etc.)?
Ayşegül YILDIZ
On the typical and atypical antipsychotics in the light of meta-analyses and our clinical experiences :Myths and realities; the correct interpretations of CATIE, CAFE,EUFEST,CutLaSS,etc.
Haldun SOYGÜR
13:15-14:45
Symposium-17 : Accurate reading and comments on meta-analyzes of Kirch and Leucth et al.
Symposia - Educational Updates Track
Moderators:
Nevzat YÜKSEL
, M. Kemal SAYAR
Where does the effectiveness of placebo stem from?
Erol GÖKA
Is the efficacy of the antidepressants significantly indifferent than placebo? Comments with regard to the meta-analysis of Kirsh et al.
Numan KONUL
Can "a country bias" be claimed in meta-analysis and comparative studies of drugs in the context of clomipramine and amisulpride examples?
Selçuk ASLAN
The antipsychotics and the results of meta-analysisfor the treatment of schizophrenia: What degree do they reflect the realities?
Köksal ALPTEKİN
18:00-19:00
Educational Interactive Course
Controversies in the diagnosis of bipolar disorder
S. Nassir GHAMIE
09:30-11:00
Symposium-F1 : Frontal lobe and cognitive functions
Frontal Lobe Functions and Beyond in Psychiatry
Moderators:
Selçuk KIRLI
, Süheyla ÜNAL
The role of frontal lobes in cognitive functions such as working memory, attention and language
Serhat ÇITAK
Frontal Lobes: What is the role of serotonin in cognitive functions?
Lütfullah BEŞİROĞLU
Noradrenergic system and cognitive functions
Şükrü UĞUZ
Frontal lobes and neural circuits
Murat EMÜL
09:30-11:00
Symposium-F2 : Dopaminergic system and addiction
Frontal Lobe Functions and Beyond in Psychiatry
Moderators:
Mansur BEYAZYÜREK
, Defne TAMAR
Dopaminergic system in addictions
Cem ŞENGÜL
Frontal lobes and dependence in the context of brain imaging
Ali saffet GÖNÜL
The approaches improving adherence in the outpatient therapy in addictions
İlhan YARGIÇ
The addictive in the etiopathogenesis of psychosis
Ayhan KALYONCU
09:30-11:00
Symposium-F1 : Mental disorders frontal lobes and cognitive functions
Frontal Lobe Functions and Beyond in Psychiatry
Moderators:
Nazmiye KAYA
, Ruhi YAVUZ
Schizophrenia and frontal lobes
Özcan UZUN
Psychotropic agents and their impact on cognitive functions
M. Alpay ATEŞ
Anxiety disorders and their effects on cognitive functions
Volkan TOPCUOĞLU
Depression and cognitive functions
Berk Murat ERGÜN